Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
90 Cards in this Set
- Front
- Back
Melphalan
|
Nitrogen mustard~ alkylating agent
|
|
Chlorambucil
|
Nitrogen mustard~ alkylating agent
|
|
Cyclophosphamide
|
Nitrogen mustard~ alkylating agent
|
|
Infosfamide
|
Nitrogen mustard~ alkylating agent
Testicular cancer |
|
Thiotepa
|
Ethylenimine ~ alkylating agent
|
|
Busulfan
|
Alkylsulfonate ~ alkylating agent
|
|
BCNU (carmustine)
|
Nitrosourea ~ alkylating agent
Malignant glioma |
|
CCNU (lomustine)
|
Nitrosourea ~ alkylating agent
|
|
Methyl CCNU (semustine)
|
Nitrosourea ~ alkylating agent
|
|
Streptozocin
|
Methylnitrosourea ~ alkylating agent
Pancreatic cancer |
|
Dacarbazine
|
Triazene ~ alkylating agent
|
|
Temozolamide
|
Triazene ~ alkylating agent
Anaplastic astrocytoma |
|
Cisplatin
|
~ alkylating agent
Testicular cancer |
|
Procarbazine
|
~ alkylating agent (DNA, RNA, and protein)
Hodgkin's lymphoma |
|
Vincristine
|
Natural product
|
|
Vinblastine
|
Natural product
|
|
Vinorelbine
|
Synthetic derivative of vinblastine
|
|
Paclitaxel (Taxol)
|
Taxane ~natural product
Breast and ovarian cancer Prevention of restenosis |
|
Abraxane
|
Protein bound nonparticle formulation of Taxol
|
|
Dacetaxel (Taxotere)
|
Synthetic analogue of Taxol
|
|
VP-16 (etoposide)
|
Epipdophyllotoxin~ natural product
Hodgkin's dz, Diffuse histiocytic lymphoma, and small cell of the lung |
|
VP-26 (teniposide)
|
Epipdophyllotoxin~ natural product
Hodgkin's dz, Diffuse histiocytic lymphoma, and small cell of the lung |
|
Irinotecan
|
Camptothecin derivative~ natural product
Lung and metstatic colon cancer |
|
Topotecan
|
Camptothecin derivative~ natural product
|
|
Dactinomycin
|
Antibiotic
Can cause radiation sensitivity |
|
Daunorubicin
|
Anthracycline~ antibiotic
Cardiotoxicity |
|
Doxorubicin
|
Anthracycline~ antibiotic
Cardiotoxicity |
|
Epirubicin
|
Anthracycline~ antibiotic
Cardiotoxicity |
|
Mitoxantrone
|
Anthracycline~ antibiotic
Cardiotoxicity |
|
Dexrazoxane
|
Fe chelator
Given to reduce cardiotoxicity from Anthracyclines |
|
Bleomycin
|
Antibiotic
DNA binding and Fe binding regions |
|
Methotrexate
|
Antimetabolite- folic acid analogue
Affects S phase of DNA cycle |
|
Leucovorin
|
Abborts MTX toxicity
|
|
Pemetrexed
|
Antimetabolite- Folate antatgonist
|
|
5-Fluorouracil
|
Antimetabolite- Pyrimidine Analogue
|
|
Floxuridine
|
Antimetabolite- Pyrimidine Analogue
|
|
Capecitabine
|
Antimetabolite- Pyrimidine Analogue
Metastatic breast and colon cancer |
|
3-deazauridine
|
Antimetabolite- Uracil analogue
|
|
6-azauridine
|
Antimetabolite- Uracil analogue
|
|
Cytosine arabinoside
|
Antimetabolite- cytidine analogue
Hematologic malignancies |
|
Gemcitabine
|
Antimetabolite- cytidine analogue
Advanced breast cancer, non small cell lung cancer, pancreatic carcinoma, ovarian cancer |
|
5-azacytidine
|
Antimetabolite- pyrimidine analogue (cytidine)
Myelodysplastic syndrome |
|
6-mercaptopurine
|
Antimetabolite- purine analogue
|
|
6-thioguanine
|
Antimetabolite- purine analogue
|
|
Pentostatin
|
Antimetabolite- purine analogue
Hairy cell leukemia |
|
Clofarabine
|
Deoxyadenosine analogue
(-) DNA poly |
|
Hydroxyurea
|
Antimetabolite
|
|
Asparaginase
|
Enzyme
|
|
Imatinib mesylate (Gleevec)
|
Biological response modifier
CML and GI stromal tumors |
|
Erlotinib
|
BRM
(-) EGF receptor tyrosine kinase |
|
Gefitinib
|
BRM
(-) EGF receptor tyrosine kinase |
|
Trastuzumab (herceptin)
|
BRM
Her2 (+) breast cancer |
|
Cetuximab
|
BRM
|
|
Bevacizumab
|
BRM
VEGF receptor |
|
Rituximab
|
BRM
Non-Hodgkin's lymphoma Can reactivate HBV |
|
Ibritumomab tiuxetan (Zevalin)
|
BRM
Linked to yttrium-90 and indium-111 |
|
Tositumomab
|
BRM
Linked to iodine-131 |
|
Gemtuzumab ozogamicin (Mylotarg)
|
BRM
Acts at Myeloid cell surface antigen CD33 |
|
Calicheamicin
|
DNA cleaving Ab conjugated to Mylotarg
|
|
Levamisole
|
BRM
|
|
IL-2 (Aldesleukin)
|
BRM
|
|
Interferon alpha
|
BRM
Multiple Myeloma Kaposi's sarcoma |
|
Thalidomide
|
BRM
Multiple Myeloma |
|
All-trans-retinoic acid
|
BRM
AML |
|
Aresenic trioxide
|
BRM
Second line for AML |
|
Bexarotene
|
BRM
Cutaneous T cell lymphoma |
|
Denileukin difitox
|
BRM
|
|
Samarium SM 153 lexidronam
|
BRM
Metastatic bone lesions |
|
Alemtuzumab
|
BRM
CLL |
|
Bortezomib
|
BRM
Multiple myeloma |
|
Celecoxib
|
BRM- COX 2 inhibitor
Prevention of cancer in familial adenomatous polyposis |
|
Pamidronate
|
Bisphosphonate
Hypercalcemia, osteolytic bone lesions in MM, metastatic breast cancer, bone metastases from solid tumors |
|
Etidronate
|
Bisphosphonate
Hypercalcemia, osteolytic bone lesions in MM, metastatic breast cancer, bone metastases from solid tumors |
|
Zoledronate
|
Bisphosphonate
Hypercalcemia, osteolytic bone lesions in MM, metastatic breast cancer, bone metastases from solid tumors |
|
bacillus Calmette-Guerin (BCG)
|
BRM
Bladder cancer |
|
Palifermin
|
BRM
Treats chemo induced mucositis |
|
Tamoxifen
|
Antiestrogen
Breast cancer in postmenopausal women |
|
Raloxifene
|
Selective estrogen receptor modulator (SERM)
|
|
Fulvestrant (Faslodex)
|
True estrogen receptor antagonist
|
|
Aminoglutethimide
|
Aromatase inhibitor
2nd line for metstatic breast cancer |
|
Anastrozole
|
Nonsteroidal Aromatase inhibitor
Alternate 1st line therapy for breast cancer |
|
Letrozole
|
Nonsteroidal Aromatase inhibitor
|
|
Megestrol
|
Progesterone agonist
Advanced breast cancer Anorexia/cachaexia Prostate cancer |
|
Medroxyprogesterone
|
Progesterone agonist
Advanced breast cancer Anorexia/cachaexia Prostate cancer |
|
Leuprolide
|
Gonadotropin-releasing hormone agonist
Prostate cancer Metstatic breast cancer in Premenopausal women |
|
Goserelin
|
Gonadotropin-releasing hormone agonist
Prostate cancer Metstatic breast cancer in Premenopausal women |
|
Flutamide
|
Nonsteroidal antiandrogen
Metastatic prostate cancer |
|
Bicalutamide
|
Nonsteroidal antiandrogen
Prostate cancer |
|
Dietheylstilbesterol
|
Old drug for prostate cancer not used anymore
|
|
Ketoconazole
|
Adrenal enzyme synthesis inhibitor
2nd line for prostate cancer |